It has been reported that the activation of the WNT5A/FZD2-induced noncanonical WNT pathway (NCWP) promotes the progression of advanced and metastatic prostate cancer and induces the epithelial-to-mesenchymal transition (EMT) in certain cancers 32. Here, WNT5A is linked to metastatic prostate carcinoma.